bn:02845725n
Noun Concept
Categories: Phenol ethers, Orphan drugs, Ureas, Receptor tyrosine kinase inhibitors, Bayer brands
EN
sorafenib  N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea  sorafenibum  4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide  ATC code L01XE05
EN
Sorafenib, sold under the brand name Nexavar, is a kinase inhibitor drug approved for the treatment of primary kidney cancer, advanced primary liver cancer, FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma. Wikipedia
Definitions
Relations
Sources
EN
Sorafenib, sold under the brand name Nexavar, is a kinase inhibitor drug approved for the treatment of primary kidney cancer, advanced primary liver cancer, FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma. Wikipedia
A small molecule drug used to treat cancer of the kidney and liver. Wiktionary